An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 9, 1998, Pages 967-974

  Porter, S N ^b   Howarth, G S ^b   Butler, R N ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b NONE

Author keywords

Breath testing; Ethane; Growth factors; Rats; Ulcerative colitis; Whey

Indexed keywords

DEXTRAN SULFATE; ETHANE; GROWTH FACTOR; PREDNISOLONE; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG; WHEY DERIVED GROWTH FACTOR EXTRACT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREATH ANALYSIS; CATTLE; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; INTESTINE INJURY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; WHEY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREATH TESTS; COLITIS, ULCERATIVE; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ETHANE; GROWTH SUBSTANCES; LIPID PEROXIDATION; MALE; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; SULFASALAZINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031702421     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655298750027001     Document Type: Article

References (27)

1. Hanauer SB. Medical therapy in ulcerative colitis. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. 4th ed. Baltimore: Williams and Wilkins; 1995. pp. 664-94.
2. Konturek SJ, Brzozowski T, Majka J, Szlachcic A, Bielanski W, Stachura J, et al. Fibroblast growth factor in gastroprotection and ulcer healing: interaction with sucralfate. Gut 1993;34:881-7.
3. Mustoe TA, Landes A, Cromack DT, Mistry D, Griffin A, Deuel TF, et al. Differential acceleration of healing of surgical incisions in the rabbit gastrointestinal tract by platelet-derived growth factor and transforming growth factor, type beta. Surgery 1990;108:324-30.
4. 2 (TGFB), but not epidermal growth factor (EGF) yields protection against dextran sulfate (DSS)-mediated colitis in mice. Gastroenterology 1992; 102:A669.
5. Sandor Z, Kusstatscher S, Szeli D, Szabo S. The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease. Orv Hetil 1995;136:1059-61.
6. Howarth GS, Xian CJ, Read LC. Insulin-like growth factor-I partially attenuates colonie damage in rats with experimental colitis induced by oral dextran sulphate sodium. Scand J Gastroenterol 1998;33:180-90.
7. Belford DA, Rogers ML, Regester GO, Francis GL, Smithers GW, Liepe IJ, et al. Milk-derived growth factors as serum supplements for the growth of fibroblast and epithelial cells. In Vitro Cell Dev Biol Anim 1995;31:750-8.
8. Francis GL, Regester GO, Webb HA, Ballard FJ. Extraction from cheese whey by cation-exchange chromatography of factors that stimulate the growth of mammalian cells. J Dairy Sci 1995;78:1209-18.
9. Howarth GS, Francis GL, Cool JC, Xu X, Byard RW, Read LC. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J Nutr 1996;126:2519-30.
10. Simmonds NJ, Rampton DS. Inflammatory bowel disease - a radical view. Gut 1993;34:865-8.
11. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, et al. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 1992;103:177-85.
12. Simmonds NJ, Allen RE, Stevens TRJ, van Someren RNM, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992;103:186-96.
13. Tamai H, Levin S, Gaginella TS. Induction of colitis in rats by 2-2′-azobis (2-amidopropane) dihydrochloride. Inflammation 1992;16:69-81.
14. Sokol RJ, Hoffenburg EJ. Antioxidants in pediatric gastrointestinal disease. Ped Clin North Am 1996;43:471-88.
15. Kokoszka J, Nelson RL, Swedler WI, Skosey J, Abcarian H. Determination of inflammatory bowel disease activity by breath pentane analysis. Dis Colon Rectum 1993;36:597-601.
16. Ondrula D, Nelson RL, Andrianopoulos G, Schwartz D, Abcarian H, Birnbaum A, et al. Quantitative determination of pentane in exhaled air correlates with colonie inflammation in the rat colitis model. Dis Colon Rectum 1993;36:457-62.
17. Sedghi S, Keshavarzian A, Klamut M, Eiznhamer D, Zarling EJ. Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. Am J Gastroenterol 1994;89:2217-21.
18. T-methylhistidine. Br J Nutr 1984;51:323-37.
19. 4-induced lipid peroxidation in the rat. J Nutr 1977;107:656-65.
20. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98: 694-702.
21. Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Shimamoto F, Brown WR. Histochemical study of colonie cancer in experimental colitis of rats. Dig Dis Sci 1993;38:529-37.
22. Cuvelier C, Mielants H, DeVos M, Quatacker J, Veys E. Idiopathic inflammatory bowel diseases: immunological hypotheses. Acta Gastroenterol Belg 1994;57:292-9.
23. Ahnfelt-Rønne I, Nielsen OH, Christensen A, Langholz E, Binder V, Riis P. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology 1990;98:1162-9.
24. Xian CJ, Shoubridge CA, Read LC. Degradation of IGF-I inthe adult rat gastrointestinal tract is limited by a specific anti-serum or the dietary protein casein. J Endocrinol 1995;146:215-25.
25. Steeb CB, Trahair JF, Tomas FM, Read LC. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 1994;266:G1090-8.
26. Owens PC, Conlon MA, Campbell RG, Johnson RJ, King R, Ballard FJ. Developmental changes in growth hormone, insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in plasma of young growing pigs. J Endocrinol 1991;128:439-47.
27. Rogers M-L, Belford DA, Francis GL, Ballard FJ. Identification of fibroblast growth factors in bovine cheese whey. J Dairy Res 1995;62:501-7.